Kymera Therapeutics
KYMR | NASDAQ
$125.85
-$1.72 (-1.35%)
At close: Nov 16, 2026, 4:00 PM ET
$123.50
-$2.35 (-1.87%)
After-hours:
Nov 16, 2026, 7:59 PM ET
Kymera Therapeutics Statistics
Key statistics explainedMarket Data
$12.6B
$11.7B
2.03
823.52K
100.1M
14.66%
N/A
NASDAQ
US5015751044
Price Performance
20.1%
3.7%
58.0%
61.7%
96.3%
547.7%
101.1%
20.1%
93.8%
15.8%
24.1%
Valuation
-34.67
N/A
10.20
-2.31
123.23
315.70
7.80
-43.61
-35.27
-43.85
114.48
-33.49
-34.29
-40.51
-2.9%
-2.3%
-2.8%
Financial Health
$971.21M
$76.6M
$971.21M
$1.77B
11.13
11.13
0.05
-0.22
-0.27
-3.75
-1,483.11
49.13
5
Margins & Profitability
174.5%
-396.1%
-333.9%
-341.9%
-282.6%
-349.4%
66.8%
-23.6%
Returns
-19.8%
-22.4%
-23.9%
-24.1%
-19.8%
Historical Growth (CAGR)
29.7%
7.8%
N/A
-20.2%
-7.2%
N/A
-31.6%
-16.3%
N/A
Analyst Forecasts
Buy
22
-23.7%
-11.6%
Feb 25, 2027
-$1.29
33.0%
$253.33K
-91.2%
Fair Value Estimates
N/A
N/A
N/A
N/A
$140.00
11.2%
Cash Flow
$-287.57M
$-288.89M
$-357.13M
-$2.89
-$2.87
-281.3%
Income Statement
$102.23M
$178.4M
$-404.89M
$-341.32M
$-349.47M
-$3.63
$374.45K
$-1.28M
273
Add to Watchlist
Select watchlists to add or remove KYMR